DV
Dividend Vision

ANNX — Annexon, Inc.

Annexon, Inc. (ANNX)

Total return is -70.2% over the past 6.1 years, 232.9 points behind SPY at 162.7%. Its deepest 1-year drawdown was 35.1%.

ANNX is a single-stock equity holding in Annexon, Inc., a clinical-stage biopharmaceutical company, rather than a diversified ETF with a formal dividend strategy. The fund does not currently offer distributions or generate meaningful yield, making it unsuitable for income-focused investors. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector, though investors should be aware of the concentrated risk and volatility associated with single-stock positions.

ANNX key facts

Asset type
Stock
Asset class
Equity
Inception date
07/24/2020
Distribution frequency
None
Last close
$5.29
Market cap
$866,727,040
Average volume
2990200.0
Beta
1.223
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.14